Active ingredientVigabatrinCat. No. P-V039-001CAS 68506-86-5Family · Pharmaceutical analytical standards
Vigabatrin
An antiepileptic that irreversibly blocks GABA transaminase, the enzyme that breaks down GABA, so raising levels of this neurotransmitter in the brain. Approved in the United Kingdom in 1989 and in the United States in 2009, it is used for infantile spasms and epilepsies resistant to other medicines. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was purpose-built to switch the enzyme off for good: it is a copy of GABA with an extra vinyl group, hence the name gamma-vinyl-GABA, and of its two mirror-image forms only one is active.
Go to the active ingredient →Active ingredientVigabatrinCat. No. P-V039-001CAS 68506-86-5
Active ingredientVigabatrin HClCat. No. P-V039-003CAS 1391054-02-6
Pharmacopoeial impurityVigabatrin EP Impurity BCat. No. P-V039-004CAS 1379403-11-8
Pharmacopoeial impurityVigabatrin EP Impurity ECat. No. P-V039-005CAS 1378466-25-1
Pharmacopoeial impurityVigabatrin EP Impurity ACat. No. P-V039-006CAS 7529-16-0
Pharmacopoeial impurityVigabatrin EP Impurity B HCl (Mixture of Z and E Isomers)Cat. No. P-V039-007
Pharmacopoeial impurityVigabatrin EP Impurity C (Mixture of Diastereomers)Cat. No. P-V039-008CAS 71107-19-2
Pharmacopoeial impurityVigabatrin EP Impurity DCat. No. P-V039-009CAS 56-12-2
Pharmacopoeial impurityVigabatrin EP Impurity F HCl (Mixture of Diastereomers)Cat. No. P-V039-010
Isotopically labelledVigabatrin-13C-d2 HydrochlorideCat. No. P-V039-011CAS 2749628-08-6
NitrosamineN-Nitroso Vigabatrin EP Impurity ACat. No. P-V039-012
Impurity(R)-VigabatrinCat. No. P-V039-013CAS 77162-51-7
Impurity(S)-VigabatrinCat. No. P-V039-014CAS 74046-07-4
ImpurityVigabatrin Impurity 1Cat. No. P-V039-015CAS 2324151-81-5
Impurity4-Acetamidohex-5-enoic acidCat. No. P-V039-016CAS 1824506-31-1
ImpurityVigabatrin Impurity 2Cat. No. P-V039-017CAS 2512190-67-7
ImpurityVigabatrin Impurity 3Cat. No. P-V039-018CAS 71107-20-5
ImpurityVigabatrin Impurity 4 HydrochlorideCat. No. P-V039-019
ImpurityVigabatrin Impurity 5Cat. No. P-V039-020
ImpurityVigabatrin Impurity 6Cat. No. P-V039-021
ImpurityVigabatrin Impurity 7 Sodium SaltCat. No. P-V039-022
ImpurityVigabatrin Impurity 8Cat. No. P-V039-023
ImpurityVigabatrin Impurity 9Cat. No. P-V039-024CAS 27428-45-1
ImpurityVigabatrin Impurity 10 HydrochlorideCat. No. P-V039-025
ImpurityVigabatrin Impurity 11Cat. No. P-V039-026No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
ImpurityVigabatrin impurity A CRSEDQM code Y0001401Family VigabatrinImpurityVigabatrin impurity B CRSEDQM code Y0001402Family VigabatrinImpurityVigabatrin impurity D CRSEDQM code Y0001404Family VigabatrinImpurityVigabatrin impurity E CRSEDQM code Y0001403Family VigabatrinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.